EUVIMEDEUVIMED entdecken
Crossref

Association of Fibrinogen Variants with Severity of Obesity and Metabolic Liver Disease: 2-Year Follow-up after Bariatric Surgery

Nadja B Pedersen iD, Anna-Marie Bloch Münster, Mette Munk Lauridsen, Yaseelan Palarasah, Charlotte W Wernberg, Lea Ladegaard Grønkjær, Birgitte G Jacobsen, Elise Jonasson, Moniek P M de Maat iD, Else-Marie Bladbjerg iD

Thrombosis and Haemostasis · 2026-03 · 126 (03) · 247-259

DOI: 10.1055/a-2615-4682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, online erschienen am 05.06.2025. Verfasst von Nadja B Pedersen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit for Thrombosis Research, Department of Clinical Biochemistry, University Hospital of Southern Denmark, Esbjerg, Denmark. Hauptthemen laut MEDLINE: Bariatric Surgery, Fibrinogen, Obesity, Liver Cirrhosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Department of Regional Health Research, the University of Southern Denmark, Region of Southern Denmark, Danish National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the hepatic manifestation of obesity. Studies in mice link fibrinogen variation to obesity and MASLD, but how naturally occurring fibrinogen variants associate with obesity and MASLD in humans is unknown. To investigate associations of fibrinogen variants (fibrinogen γ', fibrinogen αE, and sialylated fibrinogen) with obesity, MASLD, and fibrosis severity and examine changes in variants 2 years after bariatric surgery. We included 195 individuals with a body mass index (BMI) > 35 kg/m2. A subgroup of 93 individuals, who underwent bariatric surgery (n = 35) or served as nonsurgical control group (n = 58), were followed for 2 years. Hepatic tissue samples were scored for MASLD and fibrosis. Fibrinogen variants were measured using enzyme-linked immunosorbent assay. Absolute levels of fibrinogen variants tended to be higher in individuals with BMI > 45 kg/m2 compared with BMI < 40 kg/m2 (Δγ': 70 [95% confidence interval: −19, 160] µg/mL; ΔαE: 0.85 [−0.36, 2.06] µg/mL; Δsialylated: 0.09 [−0.05, 0.24] arbitrary units [AU]). Absolute and relative fibrinogen αE levels increased with MASLD (ΔαE: 2.04 [0.74, 3.35] µg/mL; ΔαE ratio: 0.05 [0.02, 0.08] %) and fibrosis (ΔαE: 1.79 [0.48, 3.11] µg/mL; ΔαE ratio: 0.05 [0.02, 0.07] %), whereas relative fibrinogen γ' levels decreased with fibrosis (Δγ' ratio: −2.52 [−4.70, −0.35] %). After bariatric surgery, sialylated fibrinogen levels were lower (Δsialylated: −0.22 [−0.32, −0.11] AU), but relative levels of the fibrinogen variants were higher (Δγ': 1.7 [0.03, 3.30] %; ΔαE: 0.03 [0.001, 0.06] %; Δsialylated: 0.02 [0.002, 0.04] AU/g/L) compared with the control group. Obesity, MASLD, and fibrosis alter fibrinogen variant profiles in plasma suggesting that fibrinogen variation plays a role in these inflammatory conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryFibrinogenObesityLiver CirrhosisFatty LiverHumansMaleFemaleMiddle AgedAdultFollow-Up StudiesBody Mass IndexSeverity of Illness IndexLiverTime FactorsTreatment OutcomeFibrinogens, Abnormal

Substanzen

Fibrinogenfibrinogen gamma'Fibrinogens, Abnormal

Autor:innen und Institutionen

  • Unit for Thrombosis Research, Department of Clinical Biochemistry, University Hospital of Southern Denmark, Esbjerg, Denmark.
  • Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • Department of Gastroenterology and Hepatology, Liver Research Group, University Hospital of Southern Denmark, Esbjerg, Denmark.
  • Department of Cancer and Inflammation Research, University of Southern Denmark, Odense, Denmark.
  • Department of Hematology, Cardiovascular Institute, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

ORCID-Profile: Nadja B Pedersen, Moniek P M de Maat, Else-Marie Bladbjerg

Förderung

  • Department of Regional Health Research, the University of Southern Denmark
  • Region of Southern Denmark
  • Danish National Research Foundation

Zitieren

APA

Pedersen, N. B., Münster, A. B., Lauridsen, M. M., Palarasah, Y., Wernberg, C. W., Grønkjær, L. L., Jacobsen, B. G., Jonasson, E., de Maat, M. P. M., & Bladbjerg, E. M. (2026). Association of Fibrinogen Variants with Severity of Obesity and Metabolic Liver Disease: 2-Year Follow-up after Bariatric Surgery. Thrombosis and Haemostasis, 126(03), 247-259. https://doi.org/10.1055/a-2615-4682

Vancouver

Pedersen NB, Münster AB, Lauridsen MM, Palarasah Y, Wernberg CW, Grønkjær LL, et al. Association of Fibrinogen Variants with Severity of Obesity and Metabolic Liver Disease: 2-Year Follow-up after Bariatric Surgery. Thrombosis and Haemostasis. 2026;126(03):247-259. doi:10.1055/a-2615-4682

BibTeX
@article{Pedersen2026,
  author = {Pedersen, Nadja B and Münster, Anna-Marie Bloch and Lauridsen, Mette Munk and Palarasah, Yaseelan and Wernberg, Charlotte W and Grønkjær, Lea Ladegaard and Jacobsen, Birgitte G and Jonasson, Elise and de Maat, Moniek P M and Bladbjerg, Else-Marie},
  title = {Association of Fibrinogen Variants with Severity of Obesity and Metabolic Liver Disease: 2-Year Follow-up after Bariatric Surgery},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  volume = {126},
  number = {03},
  pages = {247--259},
  doi = {10.1055/a-2615-4682}
}
Kostenlos starten →